Kari Pekka Pitkänen
Direktor/Vorstandsmitglied bei Scellex Oy
Vermögen: 5 Mio $ am 30.04.2024
Aktive Positionen von Kari Pekka Pitkänen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Scellex Oy | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Genna Health Oy | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Karriereverlauf von Kari Pekka Pitkänen
Ehemalige bekannte Positionen von Kari Pekka Pitkänen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AIFORIA TECHNOLOGIES OYJ | Direktor/Vorstandsmitglied | 07.03.2013 | 01.01.2021 |
Gründer | 07.03.2013 | 01.01.2023 | |
Corporate Officer/Principal | 07.03.2013 | 01.01.2023 | |
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Vertrieb & Marketing | - | - |
Ausbildung von Kari Pekka Pitkänen
Aalto University School of Science & Technology | Graduate Degree |
Statistik
International
Finnland | 6 |
Operativ
Director/Board Member | 3 |
Sales & Marketing | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Private Unternehmen | 3 |
---|---|
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
Scellex Oy | |
Genna Health Oy |
- Börse
- Insiders
- Kari Pekka Pitkänen
- Erfahrung